# Sub-Sensitivity to Long-Acting Bronchodilators (LABA)

> **NCT01117116** · NA · COMPLETED · sponsor: **National Jewish Health** · enrollment: 21 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone propionate and salmeterol
- **DRUG:** budesonide and formoterol

## Key facts

- **NCT ID:** NCT01117116
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117116, "Sub-Sensitivity to Long-Acting Bronchodilators (LABA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01117116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*